Vaishali Pharma Ltd Stock Price Today (NSE: VAISHALI)

Vaishali Pharma Ltd

7.64+0.29 (+3.95%)
Market Closed

Fundamental Score

...

Vaishali Pharma Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Vaishali Pharma Ltd share price today is 7.64, up +3.95% on NSE/BSE as of 3 August 2026. Vaishali Pharma Ltd (VAISHALI) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of 101.24 (Cr). The 52-week high for VAISHALI share price is 13.05 and the 52-week low is 4.75. At a P/E ratio of 24.34x, VAISHALI is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 6.02% and a debt-to-equity ratio of 0.27.

Vaishali Pharma Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
8.18
Low
6.96
Volume
1.3L
Change
-0.81%

Vaishali Pharma Ltd share price chart: -0.81% return over the past month. 52-week high ₹13.05, 52-week low ₹4.75.

Vaishali Pharma Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
7.217.437.217.3564.06K (Cr)
7.767.767.407.4751.95K (Cr)
7.987.986.967.399.21L (Cr)
8.008.147.387.7260.70K (Cr)
7.828.087.557.8366.92K (Cr)
8.058.057.757.8225.46K (Cr)
7.888.187.727.8423.49K (Cr)
7.728.107.527.8886.71K (Cr)
8.008.157.908.0486.27K (Cr)
7.707.937.707.931.91L (Cr)

Vaishali Pharma Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
7.208.186.967.35+2.08%
7.297.896.817.21-1.10%
7.767.906.727.05-9.15%
5.009.305.007.61+52.20%
7.197.194.754.88-32.13%
8.058.306.816.97-13.42%
8.839.807.937.97-9.74%
8.859.787.758.62-2.60%
10.1910.278.518.79-13.74%
11.5511.889.0010.04-13.07%
12.3012.7011.1211.31-8.05%
12.9013.0511.8512.24-5.12%

Returns & Performance

Poor

Return on Equity (ROE)

6.02%

Profit generated per ₹1 of shareholder equity

Return on Capital (ROCE)

N/A

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Vaishali Pharma Ltd Valuation Check

Excellent

Price to Earnings (P/E)

24.34x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

34.89x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

31.61%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Profit Growth (Quarterly YoY)

N/A

Net profit growth vs same quarter last year

Revenue Growth (Quarterly YoY)

N/A

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.27x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

3.75x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Vaishali Pharma Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of VAISHALI across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Attractive Valuation (P/E: 24.34 vs Industry: 34.89)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Conservative Debt Levels (D/E: 0.27)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

2 factors identified

Below-Average Return on Equity (6.02%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Vaishali Pharma Ltd vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare Vaishali Pharma Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
7.3/100
8
₹101.24
24.3
Average
6.02%
Poor
0.3
Excellent
0.00%
66.4/100
1991
₹468821.49
37.7
Average
15.95%
Good
20.53%
Excellent
0.1
Excellent
16.75%
Excellent
11.78%
Good
0.82%
56.3/100
8056
₹193163.97
73.6
Average
16.53%
Good
21.96%
Excellent
0.0
Excellent
5.71%
Good
8.67%
Good
0.41%
51.4/100
5123
₹169902.02
77.5
Average
27.43%
Excellent
15.19%
Good
1.8
Average
12.07%
Good
11.80%
Good
0.76%
Cipla Ltd...
CIPLA500087
40.2/100
1473
₹116131.81
30.5
Average
11.60%
Average
15.49%
Good
0.0
Excellent
9.94%
Good
8.01%
Good
0.90%
74.1/100
1078
₹115375.77
21.3
Average
21.25%
Excellent
21.14%
Excellent
0.5
Excellent
18.77%
Excellent
12.45%
Good
0.09%
Lupin Ltd...
LUPIN500257
83.4/100
2415
₹113976.53
20.0
Average
28.68%
Excellent
29.93%
Excellent
0.3
Excellent
37.02%
Excellent
13.02%
Good
0.72%
61.5/100
2470
₹105053.91
52.3
Average
13.12%
Average
13.50%
Average
0.4
Excellent
10.52%
Good
18.10%
Excellent
0.04%
41/100
1148
₹102660.46
25.6
Average
11.22%
Average
13.04%
Average
0.2
Excellent
15.44%
Excellent
12.09%
Good
0.65%
24.6/100
1580
₹90035.87
25.4
Average
10.06%
Average
12.80%
Average
0.2
Excellent
0.80%
Average
6.32%
Good
0.26%
34.1/100
1816
₹84016.75
93.9
Average
18.30%
Good
17.76%
Good
0.5
Excellent
-1.89%
Poor
7.19%
Good
0.13%

Vaishali Pharma Ltd PE Ratio History

Historical price-to-earnings ratio for VAISHALI — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20240.06₹17.49273.3x
FY 20230.59₹18.2030.8x
FY 20220.38₹13.8736.3x
FY 20210.10₹3.5836.2x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Vaishali Pharma Ltd Quarterly Performance

Latest quarterly metrics for VAISHALI — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

N/A

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

N/A

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Vaishali Pharma Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for VAISHALI — calculated from daily price history

48RSI 14
Neutral — RSI 48

Momentum is balanced — neither overbought nor oversold.

SMA 50
7
▲ Price above SMA 50 — Short-term bullish
SMA 200
8
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
113K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Vaishali Pharma Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Vaishali Pharma Ltd (VAISHALI) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Vaishali Pharma Ltd

About VAISHALI (Vaishali Pharma Ltd)

Vaishali Pharma Ltd is a dynamic pharmaceutical company committed to developing, manufacturing, and distributing a wide range of high-quality pharmaceutical products. Focused on im...proving patient health and well-being, Vaishali operates with a dedication to innovation, scientific rigor, and ethical practices. The company strives to meet the evolving healthcare needs of communities globally by offering a comprehensive portfolio of medications. Vaishali Pharma is dedicated to creating affordable and accessible solutions for various medical conditions. Through continuous research and development, state-of-the-art manufacturing facilities, and a strong commitment to quality, Vaishali Pharma aspires to be a trusted partner in healthcare. Vaishali Pharma's product line encompasses an extensive array of therapeutic categories designed to address a multitude of health concerns. The company produces and markets essential drugs covering areas such as infectious diseases, pain management, respiratory illnesses, cardiovascular health, and metabolic disorders. Vaishali’s broad portfolio includes both generic medications and specialized formulations, ensuring a wide reach and accessibility for patients. Committed to maintaining the highest standards, Vaishali Pharma adheres to stringent quality control measures throughout the production process, from raw material sourcing to final product packaging. This commitment guarantees that all products are safe, effective, and meet the rigorous requirements of regulatory bodies. Vaishali Pharma's global reach extends to numerous markets, allowing it to make a significant impact on healthcare systems around the world. The company is dedicated to expanding its presence through strategic partnerships, innovative product development, and a steadfast focus on customer satisfaction. Vaishali emphasizes strong relationships with healthcare professionals, distributors, and regulatory agencies to ensure its medications reach those who need them most. By fostering a culture of excellence and continuous improvement, Vaishali Pharma strives to remain at the forefront of the pharmaceutical industry, constantly seeking new ways to improve patient outcomes and contribute to a healthier future.

Company Details

Symbol:VAISHALI
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Atul Arvind Vasani
Chairman & MD
Mr. Hemanth Damodar Pathak
Chief Executive Officer
Mr. Dewansh Ajay Vasani
CFO & Executive Director

VAISHALI Share Price: Frequently Asked Questions

What is the current share price of Vaishali Pharma Ltd?

Vaishali Pharma Ltd (VAISHALI) trades at ₹7.64 on NSE. Market cap ₹101.24 (Cr). Educational data only.

What is the P/E ratio of Vaishali Pharma Ltd?

Vaishali Pharma Ltd has a P/E of 24.34x vs industry average 34.89x.

What is the Bull Run score for Vaishali Pharma Ltd?

Vaishali Pharma Ltd has a Bull Run score of 7.3/100 based on 25+ financial parameters.

Does Vaishali Pharma Ltd pay dividends?

Vaishali Pharma Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Vaishali Pharma Ltd?

Vaishali Pharma Ltd has ROE of 6.02%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Vaishali Pharma Ltd?

Vaishali Pharma Ltd has debt-to-equity of 0.27.

Is Vaishali Pharma Ltd a good investment?

Bull Run gives Vaishali Pharma Ltd a score of 7.3/100. This is not investment advice — consult a SEBI-registered advisor.